Armata Pharmaceuticals, Inc.
AMEX:ARMP
2.22 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.529 | 5.508 | 4.474 | 0.823 | 0 | 0 | 0.115 | 0.26 | 0.475 | 0.409 | 0.325 | 0.664 | 8.718 | 10.332 | 9.864 | 6.874 | 9.652 | 14.073 | 19.333 | 18.88 | 11.403 | 6.8 | 7.2 | 0.9 | 2.3 | 0.1 | 0.4 | 0.1 |
| Cost of Revenue
| 0.972 | 0.892 | 20.015 | 14.444 | 1.351 | 1.351 | 0.374 | 0.369 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.775 | -1.6 | -1.6 | -1.6 | -1.9 | -1.4 | -1.3 | -0.4 |
| Gross Profit
| 3.557 | 4.616 | -15.541 | -13.621 | -1.351 | -1.351 | -0.259 | -0.109 | 0.475 | 0.409 | 0.325 | 0.664 | 8.718 | 10.332 | 9.864 | 6.874 | 9.652 | 14.073 | 19.333 | 18.88 | 13.177 | 8.4 | 8.8 | 2.5 | 4.2 | 1.5 | 1.7 | 0.5 |
| Gross Profit Ratio
| 0.785 | 0.838 | -3.474 | -16.55 | 0 | 0 | -2.252 | -0.419 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.156 | 1.235 | 1.222 | 2.778 | 1.826 | 15 | 4.25 | 5 |
| Reseach & Development Expenses
| 33.77 | 35.017 | 20.015 | 14.444 | 9.824 | 4.892 | 2.881 | 5.678 | 3.992 | 5.805 | 6.502 | 1.48 | 15.183 | 17.709 | 14.482 | 18.199 | 17.288 | 17.197 | 31.315 | 31.546 | 19.312 | 14.3 | 13.3 | 13 | 11.5 | 8.2 | 6.8 | 0 |
| General & Administrative Expenses
| 11.649 | 7.437 | 8.281 | 7.966 | 9.265 | 5.702 | 7.59 | 8.413 | 6.421 | 6.85 | 8.809 | 3.208 | 5.822 | 7.029 | 6.382 | 6.313 | 6.65 | 5.49 | 8,067,000 | 6.203 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -0.972 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.289 | 1.864 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8,066,991.933 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.677 | 7.437 | 8.281 | 7.966 | 9.265 | 5.702 | 7.59 | 8.413 | 6.71 | 8.714 | 8.809 | 3.208 | 5.822 | 7.029 | 6.382 | 6.313 | 6.65 | 5.49 | 8.067 | 6.203 | 5.708 | 3.6 | 3 | 2.8 | 2.9 | 2.3 | 1.9 | 5.5 |
| Other Expenses
| 0 | -5.508 | -4.474 | -0.823 | -0.844 | 1.93 | 0.006 | -0.554 | -0.302 | 1.864 | 0 | 0.133 | 8.88 | 2.148 | 23.723 | 1.709 | 0.884 | 5.19 | 0.365 | 9.735 | 3.461 | 1.6 | 1.6 | 1.6 | 1.9 | 1.4 | 1.3 | 0.4 |
| Operating Expenses
| 44.447 | 36.946 | 23.822 | 21.587 | 19.089 | 10.594 | 10.471 | 14.091 | 10.702 | 14.519 | 15.311 | 4.688 | 21.005 | 24.738 | 44.587 | 24.512 | 23.938 | 22.687 | 39.747 | 47.484 | 28.48 | 19.5 | 17.9 | 17.4 | 16.3 | 11.9 | 10 | 5.9 |
| Operating Income
| -40.89 | -36.946 | -23.822 | -21.587 | -19.752 | -12.524 | -16.156 | -23.378 | -10.227 | -14.11 | -14.986 | -4.024 | -21.167 | -16.554 | -36.729 | -19.347 | -15.17 | -13.804 | -22.741 | -28.604 | -15.303 | -11.1 | -9.1 | -14.9 | -12.1 | -10.4 | -8.3 | -5.4 |
| Operating Income Ratio
| -9.028 | -6.708 | -5.325 | -26.23 | 0 | 0 | -140.487 | -89.915 | -21.531 | -34.499 | -46.111 | -6.06 | -2.428 | -1.602 | -3.724 | -2.815 | -1.572 | -0.981 | -1.176 | -1.515 | -1.342 | -1.632 | -1.264 | -16.556 | -5.261 | -104 | -20.75 | -54 |
| Total Other Income Expenses Net
| -28.155 | 0.029 | 0.667 | -0.594 | 0.273 | -1.844 | -3.784 | -5.563 | 9.638 | 37.219 | -40.562 | 0.103 | -8.712 | -2.148 | -22.579 | -1.048 | 0.505 | -5.007 | -1.929 | -1.78 | -28.406 | -2.8 | 0.7 | 1.1 | -13.5 | 0.8 | 8.3 | 0.4 |
| Income Before Tax
| -69.045 | -36.917 | -23.155 | -22.181 | -19.479 | -12.438 | -14.14 | -19.394 | -0.589 | 23.109 | -58.411 | -4.26 | -20.72 | -16.127 | -33.99 | -19.198 | -14.257 | -14.833 | -23.767 | -27.17 | -47.656 | -26.7 | -8.7 | -14.2 | -26 | -9.9 | -8.4 | -5.1 |
| Income Before Tax Ratio
| -15.245 | -6.702 | -5.175 | -26.951 | 0 | 0 | -122.957 | -74.592 | -1.24 | 56.501 | -179.726 | -6.416 | -2.377 | -1.561 | -3.446 | -2.793 | -1.477 | -1.054 | -1.229 | -1.439 | -4.179 | -3.926 | -1.208 | -15.778 | -11.304 | -99 | -21 | -51 |
| Income Tax Expense
| 0 | -0.029 | 0.064 | 0.634 | -0.454 | -0.328 | -1.302 | -0.556 | -0.073 | -37.219 | 43.425 | -3.15 | 20.72 | 16.127 | 33.99 | 19.198 | 14.257 | 14.833 | 23.767 | 27.17 | 47.656 | 26.7 | 8.7 | 14.2 | 26 | 9.9 | 8.4 | 5.1 |
| Net Income
| -69.045 | -36.888 | -23.219 | -22.815 | -19.025 | -12.11 | -12.838 | -18.838 | -0.516 | 23.109 | -58.411 | -1.11 | -20.72 | -16.127 | -33.99 | -19.198 | -14.257 | -14.833 | -23.767 | -27.17 | -47.656 | -26.7 | -8.7 | -14.2 | -26 | -9.9 | -8.4 | -5.1 |
| Net Income Ratio
| -15.245 | -6.697 | -5.19 | -27.722 | 0 | 0 | -111.635 | -72.454 | -1.086 | 56.501 | -179.726 | -1.672 | -2.377 | -1.561 | -3.446 | -2.793 | -1.477 | -1.054 | -1.229 | -1.439 | -4.179 | -3.926 | -1.208 | -15.778 | -11.304 | -99 | -21 | -51 |
| EPS
| -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -28.14 | -268.06 | -13.35 | 589.4 | -4,040.33 | -161.76 | -7,270.18 | -6,842.17 | -24,313.3 | -15,697.47 | -12,561.23 | -1,290.16 | -2,596.63 | -3,092.77 | -6,312.01 | -4,149.83 | -1,633.19 | -3,515.72 | -7,924.41 | -4,700.85 | -7,000 | -195.58 |
| EPS Diluted
| -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -27.34 | -268.06 | -13.35 | -326.2 | -4,040.33 | -161.76 | -7,270.18 | -6,842.17 | -24,313.3 | -15,697.47 | -12,561.23 | -1,290.16 | -2,596.63 | -3,092.77 | -6,312.01 | -4,149.83 | -1,633.19 | -3,515.72 | -7,924.41 | -4,700.85 | -7,000 | -195.58 |
| EBITDA
| -39.918 | -36.054 | -22.648 | -20.439 | -18.192 | -8.361 | -6.198 | -8.453 | -19.535 | -51.171 | 25.658 | -4.036 | -3.059 | -11.656 | -11.424 | -15.271 | -13.502 | -1.187 | -14.868 | -21.798 | 16.564 | -6.7 | -8.2 | -14.4 | 3.3 | -9.8 | -7 | -5.4 |
| EBITDA Ratio
| -8.814 | -6.546 | -5.062 | -24.835 | 0 | 0 | -53.896 | -32.512 | -41.126 | -125.112 | 78.948 | -6.078 | -0.351 | -1.128 | -1.158 | -2.222 | -1.399 | -0.084 | -0.769 | -1.155 | 1.453 | -0.985 | -1.139 | -16 | 1.435 | -98 | -17.5 | -54 |